会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 23. 发明授权
    • SGLT-2 inhibitors, methods of making them, and uses thereof
    • SGLT-2抑制剂,其制备方法及其应用
    • US08575114B2
    • 2013-11-05
    • US13052171
    • 2011-03-21
    • Shuang LiuCheng Guo
    • Shuang LiuCheng Guo
    • A01N43/04A61K31/70C07H5/04C07H5/06
    • A61K31/706
    • The present invention relates to compounds which are inhibitors of sodium dependent glucose co-transporter-2 (SGLT-2). These compounds are used in the treatment of various disorders, including diabetes, impaired glucose tolerance, insulin resistance, retinopathy, nephropathy, neuropathy, cataracts, hyperglycemia, hyperinsulinemia, hyperchlolesterolemia, elevated blood level of free fatty acids or glycerol, hyperlipidemia, hypertriglyceridemia, obesity, wound healing, tissue ischemia, atherosclerosis, and hypertension. These compounds and compositions are also useful for treating and preventing kidney stones, hyperuricemia, gout, and hyponatremia. Methods of making these compounds are also described in the present invention.
    • 本发明涉及作为钠依赖性葡萄糖共转运体-2(SGLT-2)抑制剂的化合物。 这些化合物用于治疗各种疾病,包括糖尿病,葡萄糖耐量降低,胰岛素抵抗,视网膜病变,肾病,神经病,白内障,高血糖症,高胰岛素血症,高胆固醇血症,游离脂肪酸或甘油血液水平升高,高脂血症,高甘油三酯血症,肥胖 伤口愈合,组织缺血,动脉粥样硬化和高血压。 这些化合物和组合物还可用于治疗和预防肾结石,高尿酸血症,痛风和低钠血症。 制备这些化合物的方法也在本发明中描述。